Cargando…

Fixed Triple Therapy in Chronic Obstructive Pulmonary Disease and Survival. Living Better, Longer, or Both?

Detalles Bibliográficos
Autor principal:	Vestbo, Jørgen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2020
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301727/ https://www.ncbi.nlm.nih.gov/pubmed/32212973 http://dx.doi.org/10.1164/rccm.202003-0622ED

Ejemplares similares

Triple therapy in chronic obstructive pulmonary disease: consideration under new evidence
por: Gao, Yong-Hua, et al.
Publicado: (2021)

Guidance for the Better Care of Patients with Chronic Obstructive Pulmonary Disease
por: Calverley, Peter M. A.
Publicado: (2020)

GOLD and the fixed ratio
por: Vestbo, Jørgen
Publicado: (2012)

Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
por: Singh, Dave, et al.
Publicado: (2017)

Better with Time: Reductions in Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Blagev, Denitza P.
Publicado: (2020)

The power of purpose: find meaning, live longer, better
por: Leider, Richard
Publicado: (2015)

The power of purpose: find meaning, live longer, better
por: Leider, Richard
Publicado: (2010)

Superior Bone Health for Promoting Longer and Better Lives
por: Nguyen, Vu H.
Publicado: (2021)

Cholesterol lowering: to live longer, start younger?
por: Wang, Nelson, et al.
Publicado: (2020)

Impact of health technology assessment on prescribing patterns of inhaled fixed-dose combination triple therapy in chronic obstructive pulmonary disease
por: Cook, Jennifer, et al.
Publicado: (2021)

Living better or living longer? Perceptions of patients and health care professionals in oncology
por: de Araujo Toloi, Diego, et al.
Publicado: (2015)

Living longer, working longer: the need for a comprehensive approach to labour market reform in response to demographic changes
por: Myck, Michal
Publicado: (2015)

Prognostic Value of C-Reactive Protein, Leukocytes, and Vitamin D in Severe Chronic Obstructive Pulmonary Disease
por: Moberg, Mia, et al.
Publicado: (2014)

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis
por: Papadopoulou, Efthymia, et al.
Publicado: (2023)

Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease
por: Feng, Han-Rong, et al.
Publicado: (2018)

Treatment priorities in oncology: do we want to live longer or better?
por: Marta, Guilherme Nader, et al.
Publicado: (2014)

Premature Aging of the Airway Epithelium in Chronic Obstructive Pulmonary Disease in People Living with HIV
por: Kaner, Robert J.
Publicado: (2022)

Fibrin degradation products and survival in patients with chronic obstructive pulmonary disease: a protocolized prospective observational study
por: Kamstrup, Peter, et al.
Publicado: (2023)

Donot Ignore Pulmonary Hypertension Any Longer. It's Time to Deal with it!
por: Mirdamadi, Ahmad
Publicado: (2011)

Triple fixed drug combinations in type 2 diabetes
por: John, Mathew, et al.
Publicado: (2015)

Lipids in Chronic Obstructive Pulmonary Disease: A Target for Future Therapy?
por: Vlahos, Ross
Publicado: (2020)

Is One Exacerbation Enough to Modify Therapy in Chronic Obstructive Pulmonary Disease?
por: Mannino, David M.
Publicado: (2023)

Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits
por: Mathioudakis, Alexander G, et al.
Publicado: (2020)

Real-World Experience of Treating Chronic Obstructive Pulmonary Disease with Triple Therapy
por: Liao, Kuang-Ming, et al.
Publicado: (2023)

Allergy and Chronic Obstructive Pulmonary Disease
por: Jin, Jian-Min, et al.
Publicado: (2017)

More attention to comprehensive assessment and individualized therapy of chronic obstructive pulmonary disease
por: Hou, Gang, et al.
Publicado: (2015)

Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease
por: Lock-Johansson, Sofie, et al.
Publicado: (2014)

Systematic literature review of patient-reported outcome measures used in assessment and measurement of sleep disorders in chronic obstructive pulmonary disease
por: Garrow, Adam P, et al.
Publicado: (2015)

Living Longer! Living Happier?
Publicado: (1965)

Does eating less make you live longer and better? An update on calorie restriction
por: Picca, Anna, et al.
Publicado: (2017)

Live in fear or make our lives better?
por: Goyal, Rakhee, et al.
Publicado: (2020)

Smoking cessation and chronic obstructive pulmonary disease
por: Yoo, Kwang Ha
Publicado: (2015)

Metabolic syndrome and chronic obstructive pulmonary disease
por: Koul, Parvaiz A
Publicado: (2016)

Diaphragmatic dysfunction in chronic obstructive pulmonary disease
por: Sharma, Bharat Bhushan, et al.
Publicado: (2019)

Macrolides for treatment of chronic obstructive pulmonary disease
por: Sun, Xue-Jiao, et al.
Publicado: (2019)

The Complex Beginnings of Chronic Obstructive Pulmonary Disease
por: Guerra, Stefano, et al.
Publicado: (2020)

Chronic Obstructive Pulmonary Disease: The Present and Future
por: Krishnan, Aditya, et al.
Publicado: (2022)

Interpretation of the Key Issues of Expert Consensus on Immunomodulatory Therapies for Chronic Obstructive Pulmonary Disease
por: Sun, Lina, et al.
Publicado: (2023)

Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis
por: Zheng, Yayuan, et al.
Publicado: (2018)

Prescribing pathways to triple therapy in patients with chronic obstructive pulmonary disease in the United States
por: Schabert, Vernon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5p1bs8dgp854hvioutima2rk6l